Aster Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-12
Closed -$5.22K 959
2026
Q1
$5.22K Sell
12
-886
-99% -$291K ﹤0.01% 678
2025
Q4
$315K Buy
+898
New +$303K 0.14% 138
2025
Q3
Sell
-2,705
Closed -$1.05M 1070
2025
Q2
$1.05M Buy
2,705
+2,582
+2,099% +$1.04M 0.24% 99
2025
Q1
$48.8K Buy
+123
New +$49.4K 0.01% 826
2024
Q4
Sell
-1,586
Closed -$825K 1215
2024
Q3
$825K Buy
+1,586
New +$847K 0.18% 145

Other funds holding ELV

Aster Capital Management's ELV Position: Q2 2026 in Review

Aster Capital Management sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 12 shares — an estimated $5.22K sold.

Aster Capital Management first reported a position in ELV in Q3 2024 and held it in 5 quarters. The position peaked at $1.05M in Q2 2025. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Aster Capital Management reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Aster Capital Management sold 12 Elevance Health shares in Q2 2026, an estimated $5.22K.
  • Aster Capital Management first reported a position in Elevance Health in Q3 2024 and held it in 5 quarters.
  • Aster Capital Management's Elevance Health position peaked at $1.05M in Q2 2025.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Aster Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.